Leadership In The News | Kura Oncology

Investors & Media
Contact

Home
About Us
Our Approach
Pipeline
Patients & Caregivers
- Acute Leukemias
- Head & Neck Cancer
Clinical Trials
Careers
Investors & Media
Contact
Menu Menu

PharmaVoice 100 Innovators: Dr. Stephen Dale

October 25, 2022/in Leadership In The News

https://kuraoncology.com/wp-content/uploads/AdobeStock_502590469.jpg 864 1600 David Anderson /wp-content/uploads/kura-logo.svg David Anderson2022-10-25 11:02:352022-12-01 14:02:04PharmaVoice 100 Innovators: Dr. Stephen Dale

BIO: Kura Oncology CEO Wilson on the power of biotech in the quest beyond KRAS

June 12, 2020/in Leadership In The News

https://kuraoncology.com/wp-content/uploads/troy_wilson_lab.png 478 850 David Anderson /wp-content/uploads/kura-logo.svg David Anderson2020-06-12 15:50:472022-12-01 14:05:55BIO: Kura Oncology CEO Wilson on the power of biotech in the quest beyond KRAS

About Us
Our Commitment
The Story Behind Our Name
Leadership
Board of Directors

Our Approach
Precision Medicines
Overcoming Resistance
Novel Biomarkers

Pipeline
Ziftomenib
Tipifarnib
KO-2806
Posters and Publications
Access to Investigational Drugs Outside a Clinical Study

Patients & Caregivers
Acute Leukemias
Head & Neck Cancer

Clinical Trials
Overview of Clinical Trials
Ziftomenib Clinical Trials
KOMET-001 – AML
KOMET-007 – AML
KOMET-008 – AML
Tipifarnib Clinical Trials
KURRENT-HN – HNSCC
KO-2806 Clinical Trials
FIT-001 – Solid Tumors

Investors & Media
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Analyst Coverage
FAQs
Contact

Careers
Values
Life at Kura
Benefits
Open Positions

Contact

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

Scroll to top